IDXG
Interpace Biosciences, Inc. Common Stock
IDXG
IDXG
Delisted
IDXG was delisted on the 24th of February, 2021.
28 hedge funds and large institutions have $32.9M invested in Interpace Biosciences, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
Holders
28
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$61.8K | |
| 2 | +$57.8K | |
| 3 | +$22.8K | |
| 4 |
MA
Minerva Advisors
Bala Cynwyd,
Pennsylvania
|
+$14.5K |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$7.16K |
Top Sellers
| 1 | -$326K | |
| 2 | -$69.7K | |
| 3 | -$59K | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
-$38.5K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$10K |